Comparing Cladribine vs Intron A
| Cladribine | Intron A (interferon alfa-2b) |
|
|---|
| Cladribine | Intron A (interferon alfa-2b) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hairy Cell Leukemia, Multiple Sclerosis. Cladribine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Angioblastoma, Condylomata Acuminata, Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, Hairy Cell Leukemia, Hepatitis B, Hepatitis C, Immune... View more |
Related suggestions Hairy Cell Leukemia
Popular comparisons
|
|||||||
| More about Cladribine | More about Intron A (interferon alfa-2b) | ||||||||
| Ratings & Reviews | |||||||||
|
Cladribine has an average rating of 8.0 out of 10 from a total of 10 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 20% reported a negative effect. |
Intron A has an average rating of 3.3 out of 10 from a total of 4 ratings on Drugs.com. 25% of reviewers reported a positive effect, while 75% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Cladribine side effects |
View all Intron A side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Cladribine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Cladribine Novaplus, Mavenclad |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
6.7 hours |
3 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 503 drugs are known to interact with Cladribine:
|
A total of 263 drugs are known to interact with Intron A:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
March 29, 2019 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Mavenclad
Mavenclad (cladribine) is used for the treatment of multiple sclerosis. Mavenclad information ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Zanaflex
Zanaflex (tizanidine) is a short-acting muscle relaxer used to treat spasticity by temporarily ...
Lioresal
Lioresal is used for chronic spasticity, muscle spasm, spasticity, spinal spasticity
Gablofen
Gablofen (baclofen) is used to treat severe spasticity. Includes Gablofen side effects ...
Lyvispah
Lyvispah is used to treat muscle stiffness, spasms, and pain from multiple sclerosis. It may also ...
Fleqsuvy
Fleqsuvy is used for chronic spasticity, muscle spasm, spasticity, spinal spasticity
Ozobax
Ozobax is used for chronic spasticity, muscle spasm, spasticity, spinal spasticity
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.